Physical Diseases

This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

ODYSSEY OUTCOMES Investigators Highlight at AHA that Praluent® (alirocumab) Injection Was Associated with ...
BioSpace (press release) (blog)
Praluent® (alirocumab) Injection was associated with fewer deaths from any cause among patients who had previously experienced a heart attack or unstable angina (known as acute coronary syndrome, or ACS), and this was enhanced in patients who were ...

FARXIGA Significantly Reduced Hospitalization for Heart Failure or CV Death in a Broad Patient Population with Type ...
BioSpace (press release) (blog)
FARXIGA Significantly Reduced Hospitalization for Heart Failure or CV Death in a Broad Patient Population with Type 2 Diabetes in the Landmark DECLARE-TIMI 58 Trial ... If suspected, discontinue FARXIGA, evaluate and treat promptly. Before initiating ...

Forxiga significantly reduced hospitalisation for heart failure or CV death in a broad patient population with type ...
BioSpace (press release) (blog)
"DECLARE is the largest and longest of our completed trials investigating the cardiovascular effects of a diabetes therapy. The study showed a significant reduction in the risk of heart failure, one of the most common cardiac complications of diabetes ...

FARXIGA Significantly Reduced Hospitalization for Heart Failure or CV Death in a Broad Patient Population with Type ...
BioSpace (press release) (blog)
Results from DECLARE-TIMI 58, the largest SGLT-2 inhibitor (SGLT-2i) CVOT conducted to date, including more than 17,000 patients across 33 countries, showed that FARXIGA significantly reduced the risk of hospitalization for heart failure (hHF) or CV ...

Forxiga significantly reduced hospitalisation for heart failure or CV death in a broad patient population with type ...
BioSpace (press release) (blog)
Our ambition is to modify or halt the natural course of CVRM diseases and potentially regenerate organs and restore function, by continuing to deliver transformative science that improves treatment practices and cardiovascular health for millions of ...

The Blamfluie
Joint Reconstruction Devices Market :Topmost Players : Zimmer Biomet, Medtronic Spinal, Smith & Nephew, DePuy ...
Digital Journal
Sellbyville, DE -- (SBWIRE) -- 11/11/2018 -- Rising prevalence of chronic bone disorders such as osteoporosis and rheumatoid arthritis, especially across the geriatric population, have been identified as pivotal drivers augmenting joint reconstruction ...
Joint Replacement Device Market to Surge at a Robust Pace by 2026Tactical Business

all 3 news articles »

Comic Sands
Couple Finds Love At The Hospital While Waiting For Life-Saving Transplants ?
Comic Sands
... needed simultaneous pancreas-kidney (SPK) transplants and had both had diabetes since a young age." “After our first kiss, I was nervous to see him at dialysis, but he was so lovely and natural when I did, that I needn't have worried. ... There are ...

ODYSSEY OUTCOMES investigators highlight at AHA that Praluent® (alirocumab) Injection was associated with fewer ...
PRNewswire (press release)
Praluent® (alirocumab) Injection was associated with fewer deaths from any cause among patients who had previously experienced a heart attack or unstable angina (known as acute coronary syndrome, or ACS), and this was enhanced in patients who were ...

and more »

www.MICEtimes.asia (press release)
Called the pros and cons of hormone treatment
www.MICEtimes.asia (press release)
The first disease that doctors were experimentally treated with hormones, was diabetes. By the end of the ... Hormones are divided into plant hormone remedies, bioidentical hormones and synthetic analogues of the natural hormones. The most effective of ...

www.MICEtimes.asia (press release)
Called the pros and cons of hormone treatment
www.MICEtimes.asia (press release)
In addition, it was proved that hormone replacement therapy improves survival in women with coronary heart disease. As for the ... Hormones are divided into plant hormone remedies, bioidentical hormones and synthetic analogues of the natural hormones.

The National
Dubai's Glenville Nutrition Centre aims to be a one-stop solution to women's health issues
The National
She says that many of the issues her London clinic deals with are common among women in the UAE, too - from fertility, fibroids and PCOS to weight control, osteoporosis and menopause. Glenville's latest book, Natural Solutions for Dementia and ...

People's Pharmacy: Research doesn't support claim of any significant loss of belly fat with conjugated linoleic acid
Greensboro News & Record
In the “Guide to Blood Pressure Treatment” we are sending, you will find lots of information on natural approaches, including relaxation, deep breathing and a DASH diet to maximize your intake of potassium and magnesium. These minerals are crucial for ...

and more »

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a ...
The Lancet
The magnitude of effect of sodium-glucose cotransporter-2 inhibitors (SGLT2i) on specific cardiovascular and renal outcomes and whether heterogeneity is based on key baseline characteristics remains undefined.

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a ...
The Lancet
SGLT2i reduced the risk of cardiovascular death or hospitalisation for heart failure by 23% (0·77 [0·71–0·84], p<0·0001), with a similar benefit in patients with and without atherosclerotic cardiovascular disease and with and without a history of heart ...

Business Wire (press release)
FARXIGA Significantly Reduced Hospitalization for Heart Failure or CV Death in a Broad Patient Population with Type ...
Business Wire (press release)
FARXIGA Significantly Reduced Hospitalization for Heart Failure or CV Death in a Broad Patient Population with Type 2 Diabetes in the Landmark DECLARE-TIMI 58 Trial ... If suspected, discontinue FARXIGA, evaluate and treat promptly. Before initiating ...
Forxiga significantly reduced hospitalisation for heart failure or CV death in a broad patient population with type ...Markets Insider

all 32 news articles »

Business Wire (press release)
FARXIGA Significantly Reduced Hospitalization for Heart Failure or CV Death in a Broad Patient Population with Type ...
Business Wire (press release)
Results from DECLARE-TIMI 58, the largest SGLT-2 inhibitor (SGLT-2i) CVOT conducted to date, including more than 17,000 patients across 33 countries, showed that FARXIGA significantly reduced the risk of hospitalization for heart failure (hHF) or CV ...

and more »